4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-000038
PRES./CHIEF SCIENTIFIC OFFICER acquired 3,623 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2021-12-31 | Grant or award | +3,623 | $1.66 | $6,005 | 64,958 | D |
Loading xslF345X03/form4-01032022_010112.xml…